Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioDatomics Increases NGS Research Productivity with Launch of 100 Times Faster, More Intuitive Data Analysis Software

Published: Tuesday, October 22, 2013
Last Updated: Tuesday, October 22, 2013
Bookmark and Share
The new platform addresses the shortcomings found with current data analysis offerings by delivering much higher performance and an intuitive interface.

BioDatomics have introduced the company’s first commercial product, BioDT™, an open source suite of next generation sequencing (NGS) data analysis software and services. The launch took place at the American Society of Human Genetics (ASHG) 2013 meeting in Boston, October 22-26.
 
NGS data analysis is now considered an essential tool for basic and clinical genomic research. While the Big Data generated by such research can be acquired more quickly and at a lower cost, it has become increasingly difficult to derive meaningful insights from it. Existing solutions have proven slow, with complex yet inflexible user interfaces, long turnaround times and difficult-to-interpret results. These shortcomings have meant higher costs and delays in potential breakthroughs.
 
BioDT is an open source platform capable of analyzing NGS data up to 100 times faster than similar systems, thanks to a proprietary execution engine and a Hadoop®-based architecture. Together, these techniques reduce analysis turnaround times from days—or even weeks—to hours. Further increasing productivity is BioDT’s support for real-time collaboration between geographically-dispersed colleagues. 
 
By making data analysis simple, fast and intuitive—without the need for specialized expertise in bioinformatics—BioDT promises to bring the power of NGS to a wider array of labs and researchers across the world. The platform’s drag-and-drop interface and rich data visualization eliminate the need for cumbersome Command Line Programming and reliance on tabular results (although both are supported for those who are proficient with them).  
 
“We use NGS data analysis tools extensively, and are constantly surveying the market for the latest advances,” said Indresh Singh, Core Informatics Services Lead at the J. Craig Venter Institute. “We have been looking for a fully supported open source platform that facilitates our focus on new tools and algorithms and better serves the research community. In testing BioDT, we found that it represents a true advance in this area, providing accelerated workflow execution speeds and a more intuitive user interface.” 
 
Moreover, Digicon, a large Information Technology service provider, has selected BioDT to be part of its new BioGenLink services. Digicon is a major provider of health-science related IT services to US government agencies such as the National Institutes for Health (NIH).
 
“We needed a solution that would complement our BioGenLink services and provide our customers with a powerful yet easier-to-use analysis tool,” said John Wu, Digicon CEO. “After an exhaustive survey of available options, BioDT was the obvious choice.”
 
BioDT is built on top of Red Hat Enterprise® Linux and Red Hat JBOSS Enterprise Application Platform. Similarly, much of BioDT’s accelerated analysis speed can be attributed to its use of Cloudera’s Big Data Platform and the Impala module. By combining these leading, commercial-grade, open source software technologies, BioDatomics is pioneering the use of these modules in Big Data life sciences applications. 
 
“As NGS becomes more ubiquitous in research, it’s just as important that processing power and analysis tools keep up with—and even anticipate the needs of—the researcher,” said BioDatomics CEO and Founder, Maxim Mikheev M.D., Ph.D. “With the support of our partners, we have created a next generation bioinformatics analysis platform, with which we hope to accelerate insights, advance research and reduce development costs.”
 
Additional key benefits of BioDT include:
•       Access to more than 400 commonly used analysis tools, including the entire Galaxy library
•       Graphic layout engine for customized visualization
•       Comprehensive genome browsing tools
•       Full integration with R, Bioconductor, MATLAB and Galaxy
•       mRNA, Chip, Exome and whole genome sequencing
•       Compatibility with every available NGS hardware platform 
•       Pathway, microarray and statistical analysis and visualization
 
BioDT is available in Community, Pro (site and seat licenses) and SaaS versions.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioDatomics Receives New Investment
Grant will be used to drive growth of NGS data analysis platform for greater genomic research productivity.
Friday, April 25, 2014
Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!